| 1. |
New framework needed for drug development |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
From 2005, the EU will have its own centre for disease control and prevention, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
Risperidone to olanzapine switch worth it in schizophrenia |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
Benefits of infliximab in psoriasis more than skin deep |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 5-6
L Hunt,
Preview
|
|
摘要:
Psoriasis is a highly variable, chronic disease that significantly reduces QOL. Patients with moderate-to-severe disease often require systemic therapy. Infliximab is a chimeric, anti-tumour necrosis factor-α (TNF-α) monoclonal antibody that specifically binds to human TNF-α, a key proinflammatory cytokine involved in the pathogenesis of the disease. The efficacy and QOL effect of infliximab on patients treated in the SPIRIT*trial were presented at the 62nd American Academy of Dermatology (AAD) annual meeting [Washington, DC, US; February 2004].1,2,3
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
Tiotropium bromide improves outcomes, QOL at acceptable cost |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
B-type natriuretic peptide level testing worthwhile in dyspnoea |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
Ipomoea batatasextract beneficial in type 2 diabetes |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
ONO 8815Ly inhibits uterine contractions in women |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
Oral immunotherapy with grass pollen extract safe, effective |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
Nebivolol is as effective as atenolol in reducing BP in patients with mild-to-moderate essential hypertension, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1426,
2004,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
